Elevated peripheral blood glutamate levels in major depressive disorder
Masatoshi Inoshita,1 Hidehiro Umehara,1 Shin-ya Watanabe,1 Masahito Nakataki,1 Makoto Kinoshita,1 Yukiko Tomioka,1 Atsushi Tajima,2 Shusuke Numata,1 Tetsuro Ohmori1 1Department of Psychiatry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; 2Department of Bioinformati...
Enregistré dans:
Auteurs principaux: | Inoshita M, Umehara H, Watanabe S, Nakataki M, Kinoshita M, Tomioka Y, Tajima A, Numata S, Ohmori T |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/54d0d76e83924955bf880a6f6e951cdc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pioglitazone could induce remission in major depression: a meta-analysis
par: Colle R, et autres
Publié: (2016) -
Gene expression-based biological test for major depressive disorder: an advanced study
par: Watanabe S, et autres
Publié: (2017) -
Evaluation of cognitive impairment in patients with major depressive disorder in remission
par: Mustafa Ali, et autres
Publié: (2021) -
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
par: Li G, et autres
Publié: (2016) -
Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
par: Huang Q, et autres
Publié: (2016)